• Johanna Eisele, Geoff Haynes, Knut Kreuzer, and Tiana Rosamilia.
• Evonik Industries AG, Kirschenallee, 64293 Darmstadt, Federal Republic of Germany. Electronic address: Johanna.Eisele@Evonik.com.
• Regul. Toxicol. Pharmacol. 2013 Dec 1; 67 (3): 392-408.

AbstractNeutral Methacrylate Copolymer is a fully polymerised copolymer used in the pharmaceutical industry to permit pH-independent delayed release of active ingredients from oral dosage forms. This function has potential use with food supplements and this article describes available information on the safety of the substance. Oral administration of radiolabelled copolymer to rats resulted in the detection of chemically unchanged copolymer in the faeces, with negligible absorption. Safety studies revealed no adverse toxicity following repeated administration at doses of up to 2000 mg/kg bw/d in a sub-chronic study in rats or 250 mg/kg bw/d in a sub-chronic study in dogs. No reproductive toxicity occurred at up to 2000 mg/kg bw/d in rats or rabbits. The substance shows no evidence of genotoxicity, has low acute toxicity and no irritation or sensitisation potential. An ADI value of 20 mg/kg bw was concluded from two alternative approaches. Daily exposure from use in dietary supplements is estimated as up to 10.0 mg/kg bw in adults and 13.3 mg/kg bw in children. There would therefore appear to be no safety concerns under the intended conditions of use. The information provided is intended to support an evaluation that the substance may be "generally recognized as safe" (GRAS).Copyright © 2013 Elsevier Inc. All rights reserved.

59 keywords...

hide…